Latest
  1. Johns Hopkins Bayview tells 3,182 patients an employee put their health data into a public AI tool
  2. China’s AI compute access expected to double in 2027, with US-designed chips about 65 per cent
  3. UK commits £100m to national AI Biosecurity Lab
  4. Moonshot AI releases Kimi K3.1 Pro with 1-million-token context window
  5. Residents in Newport and Cardiff oppose hyperscale datacentres near homes
  6. Study: Grok 4.7 picked Republicans in 92% of forced midterm answers, GPT-6.1 Sol picked Democrats in 97%
  7. Attackers exploiting the PHP flaws hand the break-in to AI agents, Unit 42 says
  8. Elvis Presley’s rightsholders sue Anthropic over training on 274 songs

Latest / Health and life sciences

Model releaseHealthScienceUSConfirmed

OpenAI releases GPT-Rosalind for life sciences research through trusted access

See how this story connects

Source: OpenAI: Introducing GPT-Rosalind

OpenAI introduced GPT-Rosalind, a model built for scientific research and drug discovery, offered through a trusted-access programme for eligible organisations. It later came out of research preview, became available globally to eligible organisations, and has published pricing taking effect on 5 October 2026.

Why it matters

Drug-discovery teams can apply for a biology-specialised OpenAI model, with access gated because of biosecurity risk.

When
16 Apr 2026
ID
WTA-N-2026-0163
Who
OpenAI

Summary by wheresthe.ai, from OpenAI. Checked against the source on 9 Oct 2026.

Read the original at OpenAI

Source copy: download the page text as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.

Cite this story

WTA-N-2026-0163: “OpenAI releases GPT-Rosalind for life sciences research through trusted access.” wheresthe.ai, 16 Apr 2026. https://wheresthe.ai/d/openai-gpt-rosalind-life-sciences-2026-04/ (source: OpenAI: Introducing GPT-Rosalind).

Spotted an error? Email [email protected].